Novo Nordisk to halve US list price of Wegovy from 2027 - Reuters
Novo Nordisk to halve US list price of Wegovy from 2027 Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNVTFMTVV0MFRtVjF5ZXlEbDBFR0NaZzdfVFVpRUViMllpOV9hZjJEY2lrY0VBbVJBQ015XzBKSHNDMm9uNzB3UkE3VlJUcGRkQlNGM3VOdnRyekp0NXY3MHhUNklnS0ctVnJJSlp1YnhGZlB2ajBOOU5WckJmWVA0NkdWbWNZNmtrTk1OSG9Rc0JvQUpGSUhCMmpmQXR0NUdJNUtPVHV5SGk5RUY0V19HX1ZwcXFDSWtKN3RseGZXMmI4QVdxS2JrdFZHYi0?oc=5" target="_blank">Novo Nordisk to halve US list price of Wegovy from 2027</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Weight-loss drug Wegovy to be available in pill form in UK for first time
Manufacturer Novo Nordisk says a daily tablet of the drug could be more convenient for some people than weekly injections.
June 11, 2026 at 03:00 PMUK approves Novo weight-loss pill to edge open European market - Reuters
UK approves Novo weight-loss pill to edge open European market Reuters
June 11, 2026 at 08:22 PMNovo Nordisk flags patient data breach from some clinical trials in cyberattack - Reuters
Novo Nordisk flags patient data breach from some clinical trials in cyberattack Reuters
June 11, 2026 at 09:55 PMHeart drug developer Kardigan targets $1.4 billion valuation in US IPO - Reuters
Heart drug developer Kardigan targets $1.4 billion valuation in US IPO Reuters
June 11, 2026 at 07:29 PMOpenAI considers drastic price cuts, anticipating war for users with Anthropic, WSJ reports - Reuters
OpenAI considers drastic price cuts, anticipating war for users with Anthropic, WSJ reports Reuters
June 11, 2026 at 01:45 AMDexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study - Reuters
Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study Reuters
June 6, 2026 at 06:50 PM